Koers Jubilant Pharmova Limited NSE India S.E.
Aandelen
JUBLPHARMA
INE700A01033
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
737,4 INR | +1,63% |
|
+0,50% | +35,18% |
Omzet 2022 | 61,3 mld. 734 mln. 687 mln. | Omzet 2023 | 62,82 mld. 752 mln. 704 mln. | Marktkapitalisatie | 44,42 mld. 532 mln. 498 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 4,14 mld. 49,55 mln. 46,37 mln. | Nettowinst (verlies) 2023 | -610 mln. -7,3 mln. -6,83 mln. | EV/omzet 2022 | 1,37 x |
Nettoschuld 2022 | 22,03 mld. 264 mln. 247 mln. | Nettoschuld 2023 | 26,44 mld. 317 mln. 296 mln. | EV/omzet 2023 | 1,13 x |
K/w-verhouding 2022 |
14,9
x | K/w-verhouding 2023 |
-72,8
x | Werknemers | 5.778 |
Dividendrendement 2022 |
1,29% | Dividendrendement 2023 |
1,79% | Vrij verhandelbaar | 35,19% |
1 dag | +1,63% | ||
1 week | +0,50% | ||
Lopende maand | +7,17% | ||
1 maand | +4,37% | ||
3 maanden | +30,54% | ||
6 maanden | +38,43% | ||
Lopend jaar | +35,18% |
![Extreem 715](/images/extremecours_fleche.png)
![Extreem 617.05](/images/extremecours_fleche.png)
![Extreem 532.15](/images/extremecours_fleche.png)
![Extreem 318.75](/images/extremecours_fleche.png)
![Extreem 268.9](/images/extremecours_fleche.png)
![Extreem 234.35](/images/extremecours_fleche.png)
![Extreem 115.6](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 46 | 23-05-17 | |
Chief Executive Officer | 37 | 23-05-17 | |
Arvind Chokhany
DFI | Director of Finance/CFO | 52 | 01-04-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 01-01-82 | |
Chairman | 71 | 21-06-78 | |
Chief Executive Officer | 46 | 23-05-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-06-24 | 737,4 | +1,63% | 123 101 |
25-06-24 | 725,5 | -1,00% | 86 413 |
24-06-24 | 732,8 | +1,77% | 153 021 |
21-06-24 | 720 | -1,85% | 244 070 |
20-06-24 | 733,6 | +0,32% | 165 683 |
uitgestelde koers NSE India S.E., 26 juni 2024 om 13:43 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+54,12% | 815 mld. | |
+44,25% | 654 mld. | |
-6,39% | 354 mld. | |
+21,50% | 337 mld. | |
+10,82% | 302 mld. | |
+18,45% | 247 mld. | |
+2,09% | 229 mld. | |
+13,03% | 219 mld. | |
+8,93% | 171 mld. |
- Beurs
- Aandelen
- Koers JUBLPHARMA
- Koers JUBLPHARMA